Submit Manuscript  

Article Details


In Silico and in Vitro Evaluation of Deamidation Effects on the Stability of the Fusion Toxin DAB389IL-2

[ Vol. 16 , Issue. 4 ]

Author(s):

Nasrin Zarkar, Mohammad Ali Nasiri Khalili*, Fathollah Ahmadpour, Sirus Khodadadi and Mehdi Zeinoddin   Pages 307 - 313 ( 7 )

Abstract:


Background: DAB389IL-2 (Denileukin diftitox) as an immunotoxin is a targeted pharmaceutical protein and is the first immunotoxin approved by FDA. It is used for the treatment of various kinds of cancer such as CTCL lymphoma, melanoma, and Leukemia but among all of these, treatment of CTCL has special importance. DAB389IL-2 consists of two distinct parts; the catalytic domain of Diphtheria Toxin (DT) that genetically fused to the whole IL-2. Deamidation is the most important reaction for chemical instability of proteins occurs during manufacture and storage. Deamidation of asparagine residues occurs at a higher rate than glutamine residues. The structure of proteins, temperature and pH are the most important factors that influence the rate of deamidation.

Method: Since there is not any information about deamidation of DAB389IL-2, we studied in silico deamidation by Molecular Dynamic (MD) simulations using GROMACS software. In order to, the 3D model of fusion protein DAB389IL-2 was used as a template for deamidation. Then, the stability of deamidated and native form of the drug was calculated.

Results: The results of MD simulations were showed that the deamidated form of DAB389IL-2 is more unstable than the normal form. Also, deamidation was carried by incubating DAB389IL-2, 0.3 mg/ml in ammonium hydrogen carbonate for 24 h at 37° C in order to in vitro experiment.

Conclusion: The results of in vitro experiment were confirmed outcomes of in silico study. In silico and in vitro experiments were demonstrated that DAB389IL-2 is unstable in deamidated form.

Keywords:

Deamidation, immunotoxin, protein stability, tumor, melanoma, lekemia.

Affiliation:

Department of Biosciences & Biotechnology, Malek Ashtar University of Technology, Tehran, Department of Biosciences & Biotechnology, Malek Ashtar University of Technology, Tehran, Trauma Research Centre, Baqiyatallah University of Medical Sciences, Tehran, Department of Biosciences & Biotechnology, Malek Ashtar University of Technology, Tehran, Department of Biosciences & Biotechnology, Malek Ashtar University of Technology, Tehran



Read Full-Text article